Drug
Sparc147709
Sparc147709: highest development phase Phase 1, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC147709 NCT00863174 | Phase 1 | Multiple Myeloma |
Latest
No recent events.
Follow Sparc147709 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.